Literature DB >> 22530690

Ocular application of chitosan.

Ebru Başaran1, Yasemin Yazan.   

Abstract

INTRODUCTION: A major problem in ocular therapeutics with classical formulations is the maintenance of an effective drug concentration at the site of action for a long period of time. Enhancement of ocular bioavailability with increased dose penetration and longer retention time at desired sites can be achieved by recent formulations. Chitosan stands out with its unique structural advantageous characteristics for different types of formulations like in situ gelling systems, micro- and nanoparticles, inserts, etc. AREAS COVERED: In this review, the authors focus on ocular therapeutics and the characteristics that make chitosan more acceptable in ocular applications. EXPERT OPINION: Chitosan seems to be one of the most promising polymeric carriers for both hydrophilic and lipophilic drugs for ocular application.

Mesh:

Substances:

Year:  2012        PMID: 22530690     DOI: 10.1517/17425247.2012.681775

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  9 in total

Review 1.  Application of Bioprinting in Ophthalmology.

Authors:  Yanfang Wang; Jiejie Wang; Ziyu Ji; Wei Yan; Hong Zhao; Wenhua Huang; Huan Liu
Journal:  Int J Bioprint       Date:  2022-02-22

2.  Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation.

Authors:  Ebru Başaran
Journal:  Turk J Pharm Sci       Date:  2017-08-15

3.  Polymeric micelles for the ocular delivery of triamcinolone acetonide: preparation and in vivo evaluation in a rabbit ocular inflammatory model.

Authors:  Mohamed A Safwat; Heba F Mansour; Amal K Hussein; Soha Abdelwahab; Ghareb M Soliman
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

4.  Development of topical chitosan/ β-glycerophosphate-based hydrogel loaded with levofloxacin in the treatment of keratitis: An ex-vivo study.

Authors:  Yu-Fan Chang; Yung-Hsin Cheng; Yu-Chieh Ko; Shih-Hwa Chiou; Catherine Jui-Ling Liu
Journal:  Heliyon       Date:  2021-12-30

Review 5.  Considerations for Polymers Used in Ocular Drug Delivery.

Authors:  Megan M Allyn; Richard H Luo; Elle B Hellwarth; Katelyn E Swindle-Reilly
Journal:  Front Med (Lausanne)       Date:  2022-01-28

6.  Drug-Loaded Polymeric Particulated Systems for Ophthalmic Drugs Release.

Authors:  Ruxandra Mihailovici; Alexandra Croitoriu; Florin Nedeff; Valentin Nedeff; Lacramioara Ochiuz; Decebal Vasincu; Ovidiu Popa; Maricel Agop; Andreea Moraru; Danut Costin; Marcel Costuleanu; Liliana Verestiuc
Journal:  Molecules       Date:  2022-07-14       Impact factor: 4.927

7.  Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.

Authors:  Juan Li; Shuangyan Tian; Qi Tao; Yawen Zhao; Ruyi Gui; Fan Yang; Lingquan Zang; Yanzhong Chen; Qineng Ping; Dongzhi Hou
Journal:  Int J Nanomedicine       Date:  2018-07-10

Review 8.  Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review.

Authors:  Teodora Irimia; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Dumitru Lupuleasa; Daniela-Lucia Muntean; Denisa Ioana Udeanu; Lăcrămioara Popa
Journal:  Mar Drugs       Date:  2018-10-09       Impact factor: 5.118

9.  Cyclodextrin Stabilized Freeze-Dried Silica/Chitosan Nanoparticles for Improved Terconazole Ocular Bioavailability.

Authors:  Nada Zaghloul; Nada M El Hoffy; Azza A Mahmoud; Nermeen A Elkasabgy
Journal:  Pharmaceutics       Date:  2022-02-22       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.